These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 32522095)

  • 1. Loading doses of ticagrelor versus clopidogrel in preventing periprocedural myocardial infarction in Asian patients with acute coronary syndrome.
    Zhang YR; Xue ZK; Chen KY; Xu LX; Wang WD; Tao HY; Liu T; Che JJ; Wang XW; Rha SW; Wang JR; Wang P
    Perfusion; 2021 Mar; 36(2):122-129. PubMed ID: 32522095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Crushed Ticagrelor Versus Eptifibatide Bolus Plus Clopidogrel in Troponin-Negative Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention: A Randomized Clinical Trial.
    Marian MJ; Abu Daya H; Chatterjee A; Al Solaiman F; Sasse MF; Fonbah WS; Workman RW; Johnson BE; Carlson SE; Brott BC; Prabhu SD; Leesar MA
    J Am Heart Assoc; 2019 Dec; 8(23):e012844. PubMed ID: 31766977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of Loading Doses With P2Y12-Receptor Antagonists in Patients Without Dual Antiplatelet Therapy Undergoing Elective Coronary Intervention.
    Piqueras-Flores J; Jurado-Román A; López-Lluva MT; Sánchez-Pérez I; Abellán-Huerta J; Lozano-Ruiz Poveda F
    J Cardiovasc Pharmacol; 2019 Jan; 73(1):56-59. PubMed ID: 30383607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of Different Antiplatelet Strategies in Survivors of Myocardial Infarction With Acute Coronary Syndrome.
    Xin YG; Li JL; Cao X; Liu XJ
    Clin Ther; 2019 Oct; 41(10):2090-2101.e1. PubMed ID: 31500853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ticagrelor vs Clopidogrel in Clopidogrel-Naive Patients With Chronic Coronary Syndrome.
    Manzo-Silberman S; Guedeney P; Cayla G; Beygui F; Rangé G; Motovska Z; Procopi N; Kerneis M; Zeitouni M; El Kasty M; Teiger E; Filippi E; Coste P; Huchet F; Cottin Y; Karasek J; Arnould MA; Braik N; Barthelemy O; Portal JJ; Vicaut E; Montalescot G; Silvain J;
    JACC Cardiovasc Interv; 2024 Jun; 17(12):1413-1421. PubMed ID: 38842993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator-initiated, open-label, multicentre, non-inferiority, randomised trial.
    Kim CJ; Park MW; Kim MC; Choo EH; Hwang BH; Lee KY; Choi YS; Kim HY; Yoo KD; Jeon DS; Shin ES; Jeong YH; Seung KB; Jeong MH; Yim HW; Ahn Y; Chang K;
    Lancet; 2021 Oct; 398(10308):1305-1316. PubMed ID: 34627490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry.
    D'Ascenzo F; Bertaina M; Fioravanti F; Bongiovanni F; Raposeiras-Roubin S; Abu-Assi E; Kinnaird T; Ariza-Solé A; Manzano-Fernández S; Templin C; Velicki L; Xanthopoulou I; Cerrato E; Rognoni A; Boccuzzi G; Omedè P; Montabone A; Taha S; Durante A; Gili S; Magnani G; Autelli M; Grosso A; Blanco PF; Garay A; Quadri G; Varbella F; Queija BC; Paz RC; Fernández MC; Pousa IM; Gallo D; Morbiducci U; Dominguez-Rodriguez A; Valdés M; Cequier A; Alexopoulos D; Iñiguez-Romo A; Gaita F; Rinaldi M; Lüscher TF
    Eur J Prev Cardiol; 2020 May; 27(7):696-705. PubMed ID: 30862233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Switching from ticagrelor to clopidogrel in patients with ST-segment elevation myocardial infarction undergoing successful percutaneous coronary intervention in real-world China: Occurrences, reasons, and long-term clinical outcomes.
    Li XY; Su GH; Wang GX; Hu HY; Fan CJ
    Clin Cardiol; 2018 Nov; 41(11):1446-1454. PubMed ID: 30225843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy assessment of ticagrelor versus clopidogrel in Chinese patients with acute coronary syndrome undergoing percutaneous coronary intervention by data mining and machine-learning decision tree approaches.
    Xue Y; Hu Z; Jing Y; Wu H; Li X; Wang J; Seybert A; Xie X; Lv Q
    J Clin Pharm Ther; 2020 Oct; 45(5):1076-1086. PubMed ID: 32627223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial.
    Silvain J; Lattuca B; Beygui F; Rangé G; Motovska Z; Dillinger JG; Boueri Z; Brunel P; Lhermusier T; Pouillot C; Larrieu-Ardilouze E; Boccara F; Labeque JN; Guedeney P; El Kasty M; Laredo M; Dumaine R; Ducrocq G; Collet JP; Cayla G; Blanchart K; Kala P; Vicaut E; Montalescot G;
    Lancet; 2020 Nov; 396(10264):1737-1744. PubMed ID: 33202219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of ticagrelor and clopidogrel in East Asian patients with coronary artery disease undergoing percutaneous coronary intervention.
    Li J; Qiu H; Yan L; Guo T; Wang Y; Li Y; Zheng J; Tang Y; Xu B; Qiao S; Yang Y; Gao R
    Curr Med Res Opin; 2020 Nov; 36(11):1739-1745. PubMed ID: 32945695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ticagrelor vs Clopidogrel for Complex Percutaneous Coronary Intervention in Chronic Coronary Syndrome.
    Lattuca B; Mazeau C; Cayla G; Ducrocq G; Guedeney P; Laredo M; Dumaine R; El Kasty M; Kala P; Nejjari M; Hlinomaz O; Morel O; Varenne O; Leclercq F; Payot L; Spaulding C; Beygui F; Rangé G; Motovska Z; Portal JJ; Vicaut E; Collet JP; Montalescot G; Silvain J;
    JACC Cardiovasc Interv; 2024 Feb; 17(3):359-370. PubMed ID: 38355265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of switching from ticagrelor to clopidogrel during the early and late phase in acute coronary syndrome patients after percutaneous coronary intervention.
    Wang C; Zheng W; Shaqdan A; Wang C; Qin X; Zhao X; Wang X; Yuan L; Nie S; Liu R
    Platelets; 2020; 31(3):337-343. PubMed ID: 31043110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Effectiveness and Safety of Ticagrelor Versus Clopidogrel for Elderly Chinese Patients Undergoing Percutaneous Coronary Intervention: A Single-Center Retrospective Cohort Study.
    Xu S; Liang Y; Chen Y; Gao H; Tan Z; Wang Q; Liu Y; Zhu B; Tao F; Wang Q; Zhao S; Yang L; Zhang Y; Wang Z; Han P; Chen Y; Zhang A; Li C; Lian K
    Drugs Aging; 2022 Sep; 39(9):695-703. PubMed ID: 35995912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of Ticagrelor Versus Clopidogrel Treatment in Patients With ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Tang X; Li R; Jing Q; Wang Q; Liu P; Zhang P; Liu Y
    J Cardiovasc Pharmacol; 2016 Aug; 68(2):115-20. PubMed ID: 27010809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blunting periprocedural myocardial necrosis: Rationale and design of the randomized ALPHEUS study.
    Silvain J; Cayla G; Beygui F; Range G; Lattuca B; Collet JP; Dillinger JG; Boueri Z; Brunel P; Pouillot C; Boccara F; Christiaens L; Labeque JN; Lhermusier T; Georges JL; Bellemain-Appaix A; Le Breton H; Hauguel-Moreau M; Saint-Etienne C; Caussin C; Jourda F; Motovska Z; Guedeney P; El Kasty M; Laredo M; Dumaine R; Ducrocq G; Vicaut E; Montalescot G;
    Am Heart J; 2020 Jul; 225():27-37. PubMed ID: 32473356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effect of ticagrelor on microvascular perfusion in patients with ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention.
    Wang X; Li X; Wu H; Li R; Liu H; Wang L; Bai S; Zhang L; Chen T; Liu J; Li Q; Du R
    Coron Artery Dis; 2019 Aug; 30(5):317-322. PubMed ID: 30614823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiographic outcomes in the PLATO Trial (Platelet Inhibition and Patient Outcomes).
    Kunadian V; James SK; Wojdyla DM; Zorkun C; Wu J; Storey RF; Steg PG; Katus H; Emanuelsson H; Horrow J; Maya J; Wallentin L; Harrington RA; Gibson CM
    JACC Cardiovasc Interv; 2013 Jul; 6(7):671-83. PubMed ID: 23866179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of standard and low dose ticagrelor versus clopidogrel in east AsianPatients with chronic total occlusion undergoing percutaneous coronary intervention: a single center retrospective study.
    Wang Y; Zhao HW; Wang CF; Zhang XJ; Tao J; Cui CS; Meng QK; Zhu Y; Luo DF; Hou AJ; Luan B
    BMC Cardiovasc Disord; 2020 Mar; 20(1):109. PubMed ID: 32138662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjunctive loading dose of cilostazol in preventing periprocedural myocardial infarction.
    Xu LX; Chen KY; Liu T; Zheng XT; Jiao ZQ; Xu Y; Li G
    Cardiovasc Ther; 2016 Aug; 34(4):225-33. PubMed ID: 27133311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.